Center For Venous And Lymphatic Disorders Absecon, NJ - 08205

Center For Venous And Lymphatic Disorders is categorized under Doctors in Absecon, NJ and active since 2007.

Center For Venous And Lymphatic Disorders was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Sarah Houton at the company’s single location by writing to 30 West Jimmie Leeds Road, Absecon, New Jersey NJ 08205 or by phoning (609) 652-8700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Center For Venous And Lymphatic Disorders
Contact Person: Sarah Houton
Address: 30 West Jimmie Leeds Road, Absecon, New Jersey 08205
Phone Number: (609) 652-8700
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Center For Venous And Lymphatic Disorders was started in 2007 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Sarah Houton for inquiries that concern Center For Venous And Lymphatic Disorders by calling the company number (609) 652-8700, as your correspondence is most welcome. Additionally, the physical location of the single location of Center For Venous And Lymphatic Disorders can be found at the coordinates 39.474773,-74.530799 as well as the street address 30 West Jimmie Leeds Road in Absecon, New Jersey 08205.

For its online presence, you may visit Center For Venous And Lymphatic Disorders’s website at and engage with its social media outlets through on Twitter and on Facebook.